206 related articles for article (PubMed ID: 12429473)
21. Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique.
Iwata M; McGinity JW
J Microencapsul; 1992; 9(2):201-14. PubMed ID: 1593404
[TBL] [Abstract][Full Text] [Related]
22. Improved alpha-chymotrypsin stability upon encapsulation in PLGA microspheres by solvent replacement.
Castellanos IJ; Griebenow K
Pharm Res; 2003 Nov; 20(11):1873-80. PubMed ID: 14661935
[TBL] [Abstract][Full Text] [Related]
23. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha.
Sánchez A; Tobío M; González L; Fabra A; Alonso MJ
Eur J Pharm Sci; 2003 Mar; 18(3-4):221-9. PubMed ID: 12659933
[TBL] [Abstract][Full Text] [Related]
24. Lysozyme release and polymer erosion behavior of injectable implants prepared from PLGA-PEG block copolymers and PLGA/PLGA-PEG blends.
Vesna Milacic VM; Schwendeman SP
Pharm Res; 2014 Feb; 31(2):436-48. PubMed ID: 23959854
[TBL] [Abstract][Full Text] [Related]
25. Encapsulation of protamine sulphate compacted DNA in polylactide and polylactide-co-glycolide microparticles.
Dunne M; Bibby DC; Jones JC; Cudmore S
J Control Release; 2003 Sep; 92(1-2):209-19. PubMed ID: 14499198
[TBL] [Abstract][Full Text] [Related]
26. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres.
Lam XM; Duenas ET; Cleland JL
J Pharm Sci; 2001 Sep; 90(9):1356-65. PubMed ID: 11745788
[TBL] [Abstract][Full Text] [Related]
27. Prevention of structural perturbations and aggregation upon encapsulation of bovine serum albumin into poly(lactide-co-glycolide) micropheres using the solid-in-oil-in water technique.
Castellanos IJ; Cuadrado WO; Griebenow K
J Pharm Pharmacol; 2001 Aug; 53(8):1099-107. PubMed ID: 11518019
[TBL] [Abstract][Full Text] [Related]
28. Encapsulation of BSA using a modified W/O/O emulsion solvent removal method.
Ciombor DM; Jaklenec A; Liu AZ; Thanos C; Rahman N; Weston P; Aaron R; Mathiowitz E
J Microencapsul; 2006 Mar; 23(2):183-94. PubMed ID: 16754374
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.
Morlock M; Kissel T; Li YX; Koll H; Winter G
J Control Release; 1998 Dec; 56(1-3):105-15. PubMed ID: 9801434
[TBL] [Abstract][Full Text] [Related]
30. Insulin loaded PLGA microspheres: effect of zinc salts on encapsulation, release, and stability.
Manoharan C; Singh J
J Pharm Sci; 2009 Feb; 98(2):529-42. PubMed ID: 18548615
[TBL] [Abstract][Full Text] [Related]
31. Particle size and loading efficiency of poly(D,L-lactic-co-glycolic acid) multiphase microspheres containing water soluble substances prepared by the hydrous and anhydrous solvent evaporation methods.
Iwata M; Nakamura Y; McGinity JW
J Microencapsul; 1999; 16(1):49-58. PubMed ID: 9972502
[TBL] [Abstract][Full Text] [Related]
32. Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation.
Castellanos IJ; Flores G; Griebenow K
J Pharm Sci; 2006 Apr; 95(4):849-58. PubMed ID: 16493595
[TBL] [Abstract][Full Text] [Related]
33. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.
Tobío M; Nolley J; Guo Y; McIver J; Alonso MJ
Pharm Res; 1999 May; 16(5):682-8. PubMed ID: 10350011
[TBL] [Abstract][Full Text] [Related]
34. Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: in vitro and in vivo studies and the application in the treatment of the impaired memory of mice.
Chu D; Tian J; Liu W; Li Z; Li Y
Chem Pharm Bull (Tokyo); 2007 Apr; 55(4):625-8. PubMed ID: 17409558
[TBL] [Abstract][Full Text] [Related]
35. Effect of the covalent modification with poly(ethylene glycol) on alpha-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres.
Castellanos IJ; Al-Azzam W; Griebenow K
J Pharm Sci; 2005 Feb; 94(2):327-40. PubMed ID: 15570602
[TBL] [Abstract][Full Text] [Related]
36. Double walled POE/PLGA microspheres: encapsulation of water-soluble and water-insoluble proteins and their release properties.
Shi M; Yang YY; Chaw CS; Goh SH; Moochhala SM; Ng S; Heller J
J Control Release; 2003 Apr; 89(2):167-77. PubMed ID: 12711441
[TBL] [Abstract][Full Text] [Related]
37. Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles.
Srinivasan C; Katare YK; Muthukumaran T; Panda AK
J Microencapsul; 2005 Mar; 22(2):127-38. PubMed ID: 16019899
[TBL] [Abstract][Full Text] [Related]
38. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
[TBL] [Abstract][Full Text] [Related]
39. Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres.
Meinel L; Illi OE; Zapf J; Malfanti M; Peter Merkle H; Gander B
J Control Release; 2001 Jan; 70(1-2):193-202. PubMed ID: 11166419
[TBL] [Abstract][Full Text] [Related]
40. Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process.
Cho M; Sah H
J Microencapsul; 2005 Feb; 22(1):1-12. PubMed ID: 16019886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
